BGB-A317-102

Completed

Study Investigating Safety, Tolerability, Pharmacokinetics(PK) and Antitumor Activities of Anti-PD-1(Programmed Death-1) Monoclonal Antibody

Beigene Study ID info

BGB-A317-102

ClinicalTrials.gov ID info

Study Overview

Sex: All

Age: 18 Years and older   (Adult, Older Adult)

No Study Documents

Study Overview

Sex: All

Age: 18 Years and older   (Adult, Older Adult)

No Study Documents